exp:news_feed:department site="cellbio" category_id="186" parse="inward" year="" month="" count="5"

News & Articles

Miller School of Medicine Sets New Record in NIH Research Grant Funding

The University of Miami Miller School of Medicine received a record $133.5 million in research grants from the National Institutes of Health in Federal Fiscal Year 2018 — a $12.8 million increase over the school’s FFY 2017 total, raising the school another point to No. 40 of 147 institutions in the national rankings.

Read more »

Francis S. Collins, M.D., Ph.D., left, with Barry I. Hudson, Ph.D.

Sylvester Researcher Rallies for Increased Medical Research Funding

Barry I. Hudson, Ph.D., a researcher at Sylvester Comprehensive Cancer Center and assistant professor of cell biology at the University of Miami Miller School of Medicine, attended the Rally for Medical Research held this fall in Washington, D.C.

Read more »

From left, Sandra Bacman, Ph.D., with Carlos T. Moraes, Ph.D.

Advances in Gene Editing and Delivery Offer Promise for People Living with Mitochondrial Diseases

There is strength in numbers — or at least the right proportion. A new study from University of Miami Miller School of Medicine researchers demonstrates an ability to target and reduce debilitating high levels of mutant mitochondrial DNA in heart and other muscle tissue to an extent — so far in mice — that could be curative. The findings offer hope to people living with relatively rare mitochondrial diseases.

Read more »

Feng Gong, Ph.D., enjoys the interactive aspects of teaching M.D. and M.D./MPH students and training residents.

Miller School Professors Recognized for Promoting Positive Learning Environment in PULSE 360 Survey

In all, 33 Miller School professors received high scores for promoting a positive learning environment in the first PULSE 360 Survey for Faculty-Learner Engagement. The survey was performed by the Physicians Development Program Inc., an independent organization, to allow comparison to national data and to assure anonymous feedback to individual faculty members.

Read more »

In an upcoming phase two human study, researchers will use nine outcome fields — cognitive, behavioral, psychosocial, sleep, pain, sensorimotor, cardiovascular, inflammatory biomarkers, and neuroimaging studies — to evaluate the drug’s efficacy.

‘Concussion Pill’ Shows Promise in Pre-Clinical Pilot Study

Researchers at the University of Miami Miller School of Medicine and The Miami Project to Cure Paralysis, along with their partners at Scythian Biosciences, are one step closer to finding a new treatment for concussion. In 2016, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD with an NMDA antagonist for the treatment of traumatic brain injury and concussion.

Read more »